- J&J restructures pharma manufacturing footprint at cost of up to $750MJohnson & Johnson is anticipating as much as $750 million in costs to restructure its pharmaceutical supply chain and exit factories, moves that are coming as it pushes ahead with its $55 billi…Endpoints · 9d ago↗ source
- Eli Lilly invests in Oura to support patients on GLP-1 drugsEli Lilly on Wednesday made an equity investment in wearable ring startup Oura as the drugmaker looks for ways to support patients taking its GLP-1 medications. An Oura spokesperson declined to s…Endpoints · 9d ago↗ source
- STAT+: The whistleblower, The Lab, and the fine printIn this AI Prognosis news roundup: Mayo's AI whistleblower, Sutter Health's reply to lawsuit over Abridge scribe, and more.STAT